Refractory mucosal candidiasis in patients with human immunodeficiency virus infection

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
C J Fichtenbaum, W G Powderly

Abstract

Difficult-to-manage mucosal candidal infection has been a hallmark of individuals with advanced infection due to human immunodeficiency virus type 1. In this AIDS Commentary, Drs. Fichtenbaum and Powderly comprehensively review the literature and their experience with refractory candidiasis in such patients. Of interest is their delineation of resistance, a lack of susceptibility to an antifungal agent in vitro among patients with refractory or clinically unresponsive disease. These authors believe that the establishment of resistance should be based upon standards established by the National Committee on Clinical Laboratory Standards, which they propose to define as a failure to respond to systematic therapy with specific doses of itraconazole, fluconazole, or parenterally or orally administered amphotericin B within 14 days. There have been many definitions of "refractory candidiasis," and the one proposed by these authors will be debated; however, this definition has the advantage of establishing a standard by which to judge the efficacy of their proposed algorithm for the treatment of persistent or refractory oropharyngeal candidal infections. Drs. Fichtenbaum and Powderly have performed a useful service in their attempt to...Continue Reading

Citations

Mar 16, 2013·Lasers in Medical Science·Gabriel Salles BarbérioMaria Aparecida de Andrade Moreira Machado
Apr 12, 2002·Lancet·Dimitrios P Kontoyiannis, Russell E Lewis
Dec 1, 1999·Infectious Disease Clinics of North America·L L Patton, C van der Horst
Aug 8, 2002·Oral Diseases·L P SamaranayakeP Wanzala
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
May 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C J FichtenbaumW G Powderly
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Jan 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lynne M MofensonCathy Wilfert
Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel J SkiestRandi Isaacs
Nov 11, 1999·AIDS Research and Human Retroviruses·W G PowderlyJ R Perfect
Jun 12, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·José A VazquezCarl Fichtenbaum
Feb 2, 2008·Biological & Pharmaceutical Bulletin·Mashiho YanagiMachiko Watanabe
Mar 23, 2012·Journal of Oral and Maxillofacial Pathology : JOMFP·Lalith Prakash Chandra KanthetiM Raja Rajeswari
Feb 5, 2008·International Journal of Antimicrobial Agents·Rana S TraboulsiMahmoud A Ghannoum
Mar 23, 2013·The FEBS Journal·Bao-Di DaiYuan-Ying Jiang
May 5, 2012·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Tonami IkutaYoshimitsu Abiko
Mar 11, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J Garbino
Dec 22, 1999·AIDS Research and Human Retroviruses·W G PowderlyJ R Perfect
Mar 8, 2017·Antimicrobial Agents and Chemotherapy·Luis Ostrosky-ZeichnerEric Q Wu
Sep 23, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michele I Morris, Mark Villmann
Jun 20, 2000·International Dental Journal·P A Reichart
Nov 2, 2019·Biochimica Et Biophysica Acta. Biomembranes·Arturo Galván-HernándezIván Ortega-Blake

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
W G Powderly
Enfermedades infecciosas y microbiología clínica
F J Martínez-MarcosJ Pachón-Díaz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
S L NewmanK Vigilante
© 2022 Meta ULC. All rights reserved